Literature DB >> 23065650

REV1 and DNA polymerase zeta in DNA interstrand crosslink repair.

Shilpy Sharma1, Christine E Canman.   

Abstract

DNA interstrand crosslinks (ICLs) are covalent linkages between two strands of DNA, and their presence interferes with essential metabolic processes such as transcription and replication. These lesions are extremely toxic, and their repair is essential for genome stability and cell survival. In this review, we will discuss how the removal of ICLs requires interplay between multiple genome maintenance pathways and can occur in the absence of replication (replication-independent ICL repair) or during S phase (replication-coupled ICL repair), the latter being the predominant pathway used in mammalian cells. It is now well recognized that translesion DNA synthesis (TLS), especially through the activities of REV1 and DNA polymerase zeta (Polζ), is necessary for both ICL repair pathways operating throughout the cell cycle. Recent studies suggest that the convergence of two replication forks upon an ICL initiates a cascade of events including unhooking of the lesion through the actions of structure-specific endonucleases, thereby creating a DNA double-stranded break (DSB). TLS across the unhooked lesion is necessary for restoring the sister chromatid before homologous recombination repair. Biochemical and genetic studies implicate REV1 and Polζ as being essential for performing lesion bypass across the unhooked crosslink, and this step appears to be important for subsequent events to repair the intermediate DSB. The potential role of Fanconi anemia pathway in the regulation of REV1 and Polζ-dependent TLS and the involvement of additional polymerases, including DNA polymerases kappa, nu, and theta, in the repair of ICLs is also discussed in this review.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065650      PMCID: PMC5543726          DOI: 10.1002/em.21736

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  221 in total

Review 1.  Translesion DNA synthesis polymerases in DNA interstrand crosslink repair.

Authors:  The Vinh Ho; Orlando D Schärer
Journal:  Environ Mol Mutagen       Date:  2010-07       Impact factor: 3.216

2.  BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.

Authors:  Rachel Litman; Min Peng; Zhe Jin; Fan Zhang; Junran Zhang; Simon Powell; Paul R Andreassen; Sharon B Cantor
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

3.  Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ.

Authors:  Jessica Wojtaszek; Chul-Jin Lee; Sanjay D'Souza; Brenda Minesinger; Hyungjin Kim; Alan D D'Andrea; Graham C Walker; Pei Zhou
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

Review 4.  Mutagenic repair of DNA interstrand crosslinks.

Authors:  Xi Shen; Lei Li
Journal:  Environ Mol Mutagen       Date:  2010-07       Impact factor: 3.216

5.  Phenotype-based identification of mouse chromosome instability mutants.

Authors:  Naoko Shima; Suzanne A Hartford; Ted Duffy; Lawriston A Wilson; Kerry J Schimenti; John C Schimenti
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

6.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Authors:  Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland G Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

7.  Unconventional ubiquitin recognition by the ubiquitin-binding motif within the Y family DNA polymerases iota and Rev1.

Authors:  Martha G Bomar; Sanjay D'Souza; Marzena Bienko; Ivan Dikic; Graham C Walker; Pei Zhou
Journal:  Mol Cell       Date:  2010-02-12       Impact factor: 17.970

8.  Evidence for the involvement of human DNA polymerase N in the repair of DNA interstrand cross-links.

Authors:  Laura Zietlow; Leigh Anne Smith; Mika Bessho; Tadayoshi Bessho
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

9.  Activities of human DNA polymerase kappa in response to the major benzo[a]pyrene DNA adduct: error-free lesion bypass and extension synthesis from opposite the lesion.

Authors:  Yanbin Zhang; Xiaohua Wu; Dongyu Guo; Olga Rechkoblit; Zhigang Wang
Journal:  DNA Repair (Amst)       Date:  2002-07-17

10.  Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein a.

Authors:  Adelina A Davies; Diana Huttner; Yasukazu Daigaku; Shuhua Chen; Helle D Ulrich
Journal:  Mol Cell       Date:  2008-03-14       Impact factor: 17.970

View more
  23 in total

Review 1.  A role for the base excision repair enzyme NEIL3 in replication-dependent repair of interstrand DNA cross-links derived from psoralen and abasic sites.

Authors:  Zhiyu Yang; Maryam Imani Nejad; Jacqueline Gamboa Varela; Nathan E Price; Yinsheng Wang; Kent S Gates
Journal:  DNA Repair (Amst)       Date:  2017-02-20

2.  Translesion polymerase genes polymorphisms and haplotypes influence survival of osteosarcoma patients.

Authors:  Katja Goričar; Viljem Kovač; Janez Jazbec; Branko Zakotnik; Janez Lamovec; Vita Dolžan
Journal:  OMICS       Date:  2015-03

Review 3.  Translesion DNA polymerases in eukaryotes: what makes them tick?

Authors:  Alexandra Vaisman; Roger Woodgate
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-03-09       Impact factor: 8.250

4.  The Translesion Polymerase ζ Has Roles Dependent on and Independent of the Nuclease MUS81 and the Helicase RECQ4A in DNA Damage Repair in Arabidopsis.

Authors:  Sabrina Kobbe; Oliver Trapp; Alexander Knoll; Anja Manuss; Holger Puchta
Journal:  Plant Physiol       Date:  2015-10-16       Impact factor: 8.340

5.  The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.

Authors:  Orsolya Rusz; Margit Pál; Éva Szilágyi; László Rovó; Zoltán Varga; Bernadett Tomisa; Gabriella Fábián; Levente Kovács; Olga Nagy; Petra Mózes; Zita Reisz; László Tiszlavicz; Péter Deák; Zsuzsanna Kahán
Journal:  Pathol Oncol Res       Date:  2016-07-13       Impact factor: 3.201

6.  Aberrant Kynurenine Signaling Modulates DNA Replication Stress Factors and Promotes Genomic Instability in Gliomas.

Authors:  April C L Bostian; Robert L Eoff
Journal:  Chem Res Toxicol       Date:  2016-08-15       Impact factor: 3.739

7.  Small-molecules that bind to the ubiquitin-binding motif of REV1 inhibit REV1 interaction with K164-monoubiquitinated PCNA and suppress DNA damage tolerance.

Authors:  Murugendra Vanarotti; Benjamin J Evison; Marcelo L Actis; Akira Inoue; Ezelle T McDonald; Youming Shao; Richard J Heath; Naoaki Fujii
Journal:  Bioorg Med Chem       Date:  2018-03-19       Impact factor: 3.641

8.  Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction.

Authors:  Marcelo L Actis; Nigus D Ambaye; Benjamin J Evison; Youming Shao; Murugendra Vanarotti; Akira Inoue; Ezelle T McDonald; Sotaro Kikuchi; Richard Heath; Kodai Hara; Hiroshi Hashimoto; Naoaki Fujii
Journal:  Bioorg Med Chem       Date:  2016-07-16       Impact factor: 3.641

9.  Identification of genotoxic compounds using isogenic DNA repair deficient DT40 cell lines on a quantitative high throughput screening platform.

Authors:  Kana Nishihara; Ruili Huang; Jinghua Zhao; Sampada A Shahane; Kristine L Witt; Stephanie L Smith-Roe; Raymond R Tice; Shunichi Takeda; Menghang Xia
Journal:  Mutagenesis       Date:  2015-08-04       Impact factor: 3.000

10.  Leukotriene biosynthesis inhibitor MK886 impedes DNA polymerase activity.

Authors:  Amit Ketkar; Maroof K Zafar; Leena Maddukuri; Kinrin Yamanaka; Surajit Banerjee; Martin Egli; Jeong-Yun Choi; R Stephen Lloyd; Robert L Eoff
Journal:  Chem Res Toxicol       Date:  2013-01-31       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.